WHO ICTRP trial
Prospective study on the effect of apixaban on vascular endothelial function
JPRN-jRCTs031180347 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs031180347 |
|---|---|
| Public title | Prospective study on the effect of apixaban on vascular endothelial function |
| Scientific title | Prospective exploratory study on the effect of oral administration of apixaban in vascular endothelial function in patients with non-valvular atrial fibrillation |
| Primary sponsor | Adachi Taro |
| Secondary sponsors | Bristol-Myers Squibb K.K. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Conditions | non-valvular atrial fibrillation patients;I480 |
| Interventions | Subjects are 50 patients that consented for consecutive cases of eligible non-valvular atrial fibrillation patients (at least 15 paroxysmal atrial fibrillation cases and at least 15 sustained atrial fibrillation cases). Also, more than 5… |
| Registration date | Mar 18, 2019 |
| Target size | 50 |
| Secondary IDs | UMIN000035921 |
| Registry page | jrct.niph.go.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: